By Susanna Moon
Chicago, Nov. 20 – JPMorgan Chase Financial Co. LLC priced $3.29 million of 0% review notes due Nov. 28, 2018 linked to the Celgene Corp., according to a 424B2 filing with the Securities and Exchange Commission.
The notes will be called at par plus an annualized call premium of 15.95% if the stock closes at or above its initial level on any quarterly review date.
If the notes are not called, the payout at maturity will be par unless the stock falls by more than 30%, in which case investors will be fully exposed to any losses.
The notes are guaranteed by JPMorgan Chase & Co.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Review notes
|
| Underlying stock: | Celgene Corp. (Symbol: CELG)
|
| Amount: | $3,285,000
|
| Maturity: | Nov. 28, 2018
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | Par unless stock falls by more than 30%, in which case full exposure to any losses
|
| Call: | At par plus 15.95% annualized if stock closes at or above initial level on any of four quarterly review dates
|
| Initial level: | $102.34
|
| Contingent buffer: | 30%
|
| Pricing date: | Nov. 10
|
| Settlement date: | Nov. 15
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 1%
|
| Cusip: | 48129HNN3
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
